The importance of clinical registries & biospecimen analysis in orthobiologics

admin_vjr_user — Thu, 05 Aug 2021 18:50:19 +0000

Nicolas Piuzzi, MD, Cleveland Clinic, Cleveland, OH, provides an overview of the current landscape of cellular therapies in orthopedics. Key evidence-based orthopedic cellular therapies currently being used in clinical practice include the treatment of avascular necrosis and osteoarthritis. Given current challenges around the reproducibility of orthopedic research, Dr Piuzzi proposes that in order to drive the translation of novel cell-based therapies to the clinic, more research involving large prospective cohorts and clinical registries is needed, in order to combine patient outcome data with biospecimen analysis. This interview took place during the International Society for Cell & Gene Therapy (ISCT) Annual Meeting 2021.

Direct-to-consumer marketing of unproven orthopedic therapies

admin_vjr_user — Thu, 05 Aug 2021 18:50:16 +0000

Nicolas Piuzzi, MD, Cleveland Clinic, Cleveland, OH, describes the current landscape of direct-to-consumer marketing of unproven orthopedic cell-based therapies, a major challenge facing the field of orthopedics that can put patients at risk, both medically and financially. Dr Piuzzi highlights the importance for international societies to continue to work together to provide reliable, unbiased information that patients can trust, allowing them to make informed treatment decisions. He notes that researchers and clinicians also have the responsibility to continue to advance research and conduct clinical effectiveness studies so that more therapies can be covered by health insurance. This interview took place during the International Society for Cell & Gene Therapy (ISCT) Annual Meeting 2021.

Nicolas Piuzzi – VJRegenMed

The importance of clinical registries & biospecimen analysis in orthobiologics

Direct-to-consumer marketing of unproven orthopedic therapies